SCHEMBL2117698

SCHEMBL2117698

CCCCCCCCCCCCCC(=O)C(C)(NC)C(=O)OC(CCCCCC)CCCCCCCCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 8/20 0.40
▸ CES1 P23141 5/20 0.40
▸ CES2 O00748 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ZDHHC7 Q9NXF8 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ PRSS1 P07477 1/20 0.39
▸ CTSG P08311 1/20 0.39
▸ CTRB1 P17538 1/20 0.39
▸ CMA1 P23946 1/20 0.39
▸ LMNA P02545 4/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ USP2 O75604 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ NOD1 Q9Y239 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28919223 0.78 FAAH (0.53) FAAHCES1CES2MEN1CYP1A2
SCHEMBL28821758 0.78 EPHX1 (0.49) FAAHCES1CES2MEN1CYP1A2
SCHEMBL31133509 0.77 ZDHHC7 (0.41) FAAHMEN1KMT2AZDHHC7MAPT
SCHEMBL29707920 0.76 PRKCA (0.46) FAAHZDHHC7MAPTMAPK1PRSS1
SCHEMBL29707921 0.76 PRKCA (0.46) FAAHZDHHC7MAPTMAPK1PRSS1
SCHEMBL29707916 0.76 PRKCA (0.46) FAAHZDHHC7MAPTMAPK1PRSS1
SCHEMBL29707919 0.76 PRKCA (0.46) FAAHZDHHC7MAPTMAPK1PRSS1
SCHEMBL29707924 0.76 PRKCA (0.46) FAAHZDHHC7MAPTMAPK1PRSS1
SCHEMBL594327 0.76 PRKCA (0.46) FAAHZDHHC7MAPTMAPK1PRSS1
SCHEMBL29707922 0.76 PRKCA (0.46) FAAHZDHHC7MAPTMAPK1PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055665-A1 DELIVERY CARRIER INTO CELL ITO, KABUSIKIKAISYA (JP) 2023-02-23 — — US claimed
WO-2020145495-A1 COSMETIC COMPOSITION COMPRISING COSMETIC CAPSULES INTO WHICH WATER-SOLUBLE EXTRACT IS ABSORBED 한국콜마주식회사 2020-07-16 — — WO claimed
EP-4534149-A1 GELATION AGENT COMPOSITION AJINOMOTO CO., INC. (JP) 2025-04-09 — — EP disclosed
CN-119523900-A Method for entrapping silymarin and aesculin composition by low energy method and application of silymarin and aesculin composition in anti-allergic and anti-inflammatory products 江南大学附属医院 2025-02-28 — — CN disclosed
US-20240099955-A1 SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF HTL BIOTECHNOLOGY INNOVATION INC. 2024-03-28 — — US disclosed
EP-4288084-A1 SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF Modern Meadow, Inc. (US) 2023-12-13 — — EP disclosed
CN-113286574-B Cosmetic composition comprising a cosmetic capsule absorbing a water-soluble extract 韩国科玛株式会社 2023-05-30 — — CN disclosed
US-20230055665-A1 DELIVERY CARRIER INTO CELL ITO, KABUSIKIKAISYA (JP) 2023-02-23 — — US disclosed
US-11540990-B2 Oil composition and cosmetic containing the same AJINOMOTO CO., INC. (JP) 2023-01-03 — — US disclosed
US-11497705-B2 Anhydrous liquid composition comprising oils, a film-forming polymer, a monoalcohol and a particulate material L'OREAL (FR) 2022-11-15 — — US disclosed
WO-2022170114-A1 SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF MODERN MEADOW, INC. (US) 2022-08-11 — — WO disclosed
US-20090081142-A1 External Preparation for Skin SHISEIDO COMPANY LTD. 2009-03-26 — — US disclosed
EP-2026746-A2 SELF TANNING COMPOSITION Ciba Holding Inc. (CH) 2009-02-25 — — EP disclosed
WO-2009016064-A1 USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS BASF SE (CH) 2009-02-05 — — WO disclosed
US-20080318900-A1 Cosmetic Compositions Comprising At Least One Bis-Urea Derivative L'OREAL S.A. (FR) 2008-12-25 — — US disclosed
WO-2008107347-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (CH) 2008-09-12 — — WO disclosed
EP-1955691-A1 EXTERNAL PREPARATION FOR SKIN Shiseido Company, Limited (JP) 2008-08-13 — — EP disclosed
WO-2008080892-A1 UV ABSORBER FORMULATIONS CIBA HOLDING INC. (CH) 2008-07-10 — — WO disclosed
WO-2007137958-A2 SELF TANNING COMPOSITION CIBA HOLDING INC. (CH) 2007-12-06 — — WO disclosed
JP-2007112767-A EMULSION COSMETIC POLA CHEM IND INC 2007-05-10 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055665-A1 DELIVERY CARRIER INTO CELL CTSA, ATG4A, ATG7 FAAH 1364/4885CES1 202/4885CES2 1421/4885
US-20090081142-A1 External Preparation for Skin CUTA, MMS19, ALAD FAAH 603/4885CES1 697/4885CES2 393/4885
US-11497705-B2 Anhydrous liquid composition comprising oils, a film-forming polymer, a monoalcohol and a particulate material KRT18, VIM, DSG1 FAAH 3832/4885CES1 4368/4885CES2 4310/4885
US-20080318900-A1 Cosmetic Compositions Comprising At Least One Bis-Urea Derivative KRT18, DEGS1, DSG1 FAAH 363/4885CES1 368/4885CES2 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback